Wasatch Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-410,510
| Closed | -$24.6M | – | 268 |
|
|
2021
Q4 | $24.6M | Buy |
410,510
+111,540
| +37% | +$6.68M | 0.1% | 160 |
|
|
2021
Q3 | $25.7M | Buy |
298,970
+911
| +0.3% | +$78.3K | 0.1% | 155 |
|
|
2021
Q2 | $33.2M | Buy |
298,059
+32,086
| +12% | +$3.57M | 0.13% | 142 |
|
|
2021
Q1 | $29.6M | Sell |
265,973
-62,279
| -19% | -$6.94M | 0.13% | 133 |
|
|
2020
Q4 | $34.9M | Buy |
328,252
+46,335
| +16% | +$4.92M | 0.17% | 111 |
|
|
2020
Q3 | $39.2M | Buy |
281,917
+105,548
| +60% | +$14.7M | 0.25% | 97 |
|
|
2020
Q2 | $57M | Sell |
176,369
-123,698
| -41% | -$40M | 0.41% | 77 |
|
|
2020
Q1 | $26.8M | Sell |
300,067
-323,502
| -52% | -$28.9M | 0.28% | 82 |
|
|
2019
Q4 | $24.7M | Buy |
623,569
+70,023
| +13% | +$2.77M | 0.2% | 100 |
|
|
2019
Q3 | $13.6M | Sell |
553,546
-7,765
| -1% | -$191K | 0.13% | 120 |
|
|
2019
Q2 | $19.8M | Buy |
561,311
+73,943
| +15% | +$2.61M | 0.19% | 105 |
|
|
2019
Q1 | $21.8M | Buy |
487,368
+42,540
| +10% | +$1.9M | 0.24% | 83 |
|
|
2018
Q4 | $21.4M | Buy |
444,828
+47,505
| +12% | +$2.28M | 0.28% | 80 |
|
|
2018
Q3 | $26.5M | Buy |
397,323
+169,140
| +74% | +$11.3M | 0.3% | 77 |
|
|
2018
Q2 | $10.7M | Buy |
228,183
+14,576
| +7% | +$686K | 0.13% | 110 |
|
|
2018
Q1 | $12.1M | Sell |
213,607
-8,434
| -4% | -$477K | 0.16% | 101 |
|
|
2017
Q4 | $11M | Sell |
222,041
-2,237
| -1% | -$111K | 0.15% | 114 |
|
|
2017
Q3 | $17.1M | Buy |
224,278
+6,710
| +3% | +$510K | 0.23% | 91 |
|
|
2017
Q2 | $20.5M | Buy |
217,568
+66,109
| +44% | +$6.22M | 0.29% | 80 |
|
|
2017
Q1 | $12M | Sell |
151,459
-2,269
| -1% | -$180K | 0.18% | 100 |
|
|
2016
Q4 | $12.8M | Sell |
153,728
-1,401
| -0.9% | -$117K | 0.19% | 100 |
|
|
2016
Q3 | $17.4M | Sell |
155,129
-1,217
| -0.8% | -$136K | 0.26% | 92 |
|
|
2016
Q2 | $17.3M | Sell |
156,346
-1,434
| -0.9% | -$159K | 0.27% | 91 |
|
|
2016
Q1 | $16.3M | Sell |
157,780
-3,743
| -2% | -$388K | 0.25% | 106 |
|
|
2015
Q4 | $13M | Buy |
161,523
+1,697
| +1% | +$137K | 0.18% | 130 |
|
|
2015
Q3 | $11.1M | Sell |
159,826
-3,434
| -2% | -$238K | 0.15% | 153 |
|
|
2015
Q2 | $16M | Buy |
163,260
+3,151
| +2% | +$309K | 0.17% | 152 |
|
|
2015
Q1 | $15.7M | Buy |
160,109
+2,408
| +2% | +$236K | 0.16% | 138 |
|
|
2014
Q4 | $17.4M | Buy |
157,701
+146,444
| +1,301% | +$16.1M | 0.18% | 128 |
|
|
2014
Q3 | $1.33M | Buy |
11,257
+9,379
| +499% | +$1.11M | 0.01% | 341 |
|
|
2014
Q2 | $244K | Buy |
+1,878
| New | +$244K | ﹤0.01% | 384 |
|